US Stock Moving | Starbucks reportedly considering acquisition, Chipotle Mexican Grill (CMG.US) shares soar up to 8.6%
According to media reports citing sources familiar with the matter, Starbucks has been working with advisors in recent months to explore potential acquisition plans targeting the US-based Mexican-style restaurant chain Chipotle Mexican Grill.
According to the Jinse Finance APP, citing sources familiar with the matter, Starbucks (SBUX.US) has been working with advisors over the past few months to explore a potential acquisition plan for the US Mexican-style chain restaurant company Chipotle Mexican Grill (CMG.US). After the news broke, Chipotle Mexican Grill's share price soared as much as 8.6% intraday on Thursday, while Starbucks' share price fell as much as 6.7%, marking its largest intraday drop in over a year. As of press time, Chipotle Mexican Grill's share price had narrowed its gain to 5.3%, trading at $32,385.
The report pointed out that it is currently unclear how far Starbucks' potential acquisition plan has progressed. Considering the deal could be very large in scale, the acquisition may ultimately not proceed. Therefore, discussions are still highly uncertain and it cannot yet be determined whether the two parties will reach a formal transaction.
It is worth noting that Starbucks' current Chief Executive Officer, Brian Niccol, has close ties with Chipotle Mexican Grill. Niccol became Starbucks CEO in 2024, having previously served as Chief Executive Officer at Chipotle Mexican Grill. His familiarity with the company's business and operating model has brought significant market attention to this potential transaction.
However, as of now, the report has not revealed the potential acquisition price, financing arrangements, or specific timetable, and whether Starbucks will make a formal acquisition offer remains to be seen.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Morgan Stanley senior bond investor turns bullish on US Treasuries for the first time in ten years
US Stock Movement | SuperX AI Technology (SUPX.US) once fell more than 2.5%, hitting an intraday low of $6.46
SuperX AI Technology's stock price declined, falling more than 2.5% at one point.
BUZZ-Pacira BioSciences participated in a Viatris acquisition deal worth 1.65 billions dollars
Latest Update October 8 – Pacira BioSciences (PCRX.O) shares surged by 44%, hitting a more than three-year high at $36.30. If the rally holds, PCRX is poised for its largest single-day gain on record. Pharmaceutical company Viatris (VTRS.O) will acquire Pacira BioSciences in a $1.65 billion cash deal, offering $36.50 per share. The offer represents a premium of approximately 44.8% over Pacira’s recent closing price of $25.20. The transaction will add Pacira’s non-opioid pain medications Exparel and Zilretta to Viatris' product portfolio. Viatris shares fell 2.6% to $17.04. JPMorgan stated: “We believe this acquisition will not significantly alter VTRS' overall financial profile in the short or long term, and expect Exparel’s sales to gradually decline post-2030 due to generic market entry.” Both parties expect to complete the transaction by the end of 2026. Including intraday fluctuations, PCRX shares have risen 40.2% year-to-date, while VTRS has gained 36.8%. (For the convenience of non-English speakers, Reuters provides automated translations of its reports into several other languages. As automated translation may contain errors or lack the necessary context, Reuters does not guarantee the accuracy of automated translated texts and provides them for readers’ convenience only. Reuters assumes no liability for any damage or losses resulting from the use of automated translation.)
